- Filed
- May 15, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · May 15, 2025 | 400M sh |
| Capex | Q2 2025 · Mar 31, 2025 | $38.59K |
| Capex | Q2 2025 · Mar 31, 2024 | $58.6K |
| Short Term Debt | Q2 2025 · Mar 31, 2025 | $98.12K |
| Cash And Equivalents | Q2 2025 · Mar 31, 2025 | $27.38K |
| Cash And Equivalents | Q2 2025 · Sep 30, 2024 | $82.18K |
| Stockholders Equity | Q2 2025 · Mar 31, 2025 | −$7.85M |
| Stockholders Equity | Q2 2025 · Sep 30, 2024 | −$7.18M |
| Current Liabilities | Q2 2025 · Mar 31, 2025 | $8.66M |
| Current Liabilities | Q2 2025 · Sep 30, 2024 | $8.55M |
| Total Liabilities | Q2 2025 · Mar 31, 2025 | $8.66M |
| Total Liabilities | Q2 2025 · Sep 30, 2024 | $8.67M |
| Current Assets | Q2 2025 · Mar 31, 2025 | $328.21K |
| Current Assets | Q2 2025 · Sep 30, 2024 | $548.52K |
| Total Assets | Q2 2025 · Mar 31, 2025 | $804.28K |
| Total Assets | Q2 2025 · Sep 30, 2024 | $1.48M |
| Operating Cash Flow | Q2 2025 · Sep 30, 2024 | $17.88K |
| Operating Cash Flow | Q2 2025 · Mar 31, 2024 | −$390.01K |
| Shares Diluted | Q2 2025 · Mar 31, 2024 | 400M sh |
| Shares Diluted | Q2 2025 · Mar 31, 2024 | 400M sh |
| Eps Diluted | Q2 2025 · Mar 31, 2024 | −$0.00 |
| Eps Diluted | Q2 2025 · Mar 31, 2024 | −$0.00 |
| Eps Basic | Q2 2025 · Mar 31, 2024 | −$0.00 |
| Eps Basic | Q2 2025 · Mar 31, 2024 | −$0.00 |
| Net Income | Q2 2025 · Mar 31, 2024 | −$577K |
| Net Income | Q2 2025 · Mar 31, 2024 | −$1.1M |
| Operating Income | Q2 2025 · Mar 31, 2024 | −$583.63K |
| Operating Income | Q2 2025 · Mar 31, 2024 | −$1.15M |
| Gross Profit | Q2 2025 · Mar 31, 2024 | $265.05K |
| Gross Profit | Q2 2025 · Mar 31, 2024 | $678.28K |
| Cost Of Revenue | Q2 2025 · Mar 31, 2024 | $99.46K |
| Cost Of Revenue | Q2 2025 · Mar 31, 2024 | $248.38K |
| Revenue | Q2 2025 · Mar 31, 2024 | $364.51K |
| Revenue | Q2 2025 · Mar 31, 2024 | $926.67K |